Ultra Clean Holdings, Inc. — Q3 2017 Form 10-Q
Business context and reporting period. Ultra Clean designs and manufactures tools, modules and subsystems, primarily for semiconductor equipment makers, with additional exposure to consumer, medical and other industries. This unaudited filing covers the quarter and nine months ended September 29, 2017; comparisons are to the corresponding 2016 periods ended September 23, 2016. The company reports one operating segment.
Financial performance and position
| Metric | Q3 2017 | Q3 2016 | Nine months 2017 | Nine months 2016 |
|---|---|---|---|---|
| Sales | $242.6 million | $146.2 million | $675.5 million | $388.2 million |
| Gross profit / margin | $42.7 million / 17.6% | $23.5 million / 16.1% | $123.6 million / 18.3% | $57.1 million / 14.7% |
| Operating income | $23.3 million | $6.7 million | $67.4 million | $9.7 million |
| Net income | $19.7 million | $2.6 million | $54.2 million | $0.1 million |
| Diluted EPS | $0.57 | $0.08 | $1.59 | $0.00 |
- Cash flow: Nine-month operating cash flow was $37.6 million, compared with $9.4 million in 2016. Investing used $12.5 million and financing used $11.7 million. Cash increased $13.5 million to $65.9 million.
- Liquidity and working capital: At September 29, cash was $65.9 million; receivables were $107.7 million and inventory was $165.3 million. Inventory rose from $103.9 million at December 30, 2016, while accounts receivable rose from $74.7 million.
- Debt: Total bank debt was reported as $57.3 million; contractual obligations list approximately $57.5 million gross of debt issuance costs. U.S. facilities had $0.1 million available and the Czech facility approximately $5.8 million available. The company was in compliance with its credit covenants.
- Other: Total assets were $500.8 million and stockholders’ equity was $276.7 million. The company reported $169.2 million of inventory purchase commitments.
Material changes versus the prior comparable periods
- Q3 sales increased 66.0%; nine-month sales increased 74.0%. Management attributed growth principally to higher semiconductor customer demand and shipment volumes.
- Margins improved: Q3 gross margin rose 1.5 percentage points and nine-month gross margin rose 3.6 points. Management cited higher volume, improved factory utilization and labor efficiency.
- Operating expenses increased in dollars but fell as a share of sales: 8.0% versus 11.5% in Q3 and 8.3% versus 12.2% year to date.
- Nine-month operating cash flow improved, but growth absorbed substantial working capital: receivables increased cash use by $32.4 million and inventory by $60.5 million, partly offset by a $57.7 million increase in accounts payable.
- Two customers, Lam Research and Applied Materials, together accounted for 83.6% of Q3 sales and 84.0% of nine-month sales. Lam alone represented 59.1% and 58.3%, respectively.
Outlook, commentary and risks
- Management expected Q4 2017 sales and gross profit to be relatively flat compared with Q3; no specific numerical guidance was provided.
- Management said cash, operating cash flow and available credit were expected to meet debt service and working-capital needs for at least the next 12 months. The U.S. credit agreement requires a minimum quarter-end cash balance of $35 million and restricts cash dividends.
- Approximately $61.2 million of cash was held by foreign subsidiaries and may be subject to U.S. tax if repatriated for U.S. operations. The company intended to reinvest those funds outside the U.S.
- Key risks include semiconductor-industry cyclicality, customer concentration and pricing leverage, supplier constraints, order cancellations or delays, inventory obsolescence, foreign-exchange and international operating exposure, and execution of the company-wide ERP implementation. Management warned that ERP implementation could disrupt operations or financial reporting and incur further expense.
- The company recorded $0.3 million of other income from reducing the Miconex acquisition earn-out liability to zero after the second-year performance target was missed. No material adverse effect from ordinary-course legal proceedings was expected. Disclosure controls were assessed as effective, with no material change in internal control over financial reporting reported for the quarter.
Important facts for investors to verify
- Reconcile the MD&A’s Q3 U.S. sales figure of $110.6 million with the geographic revenue table’s U.S. figure of $138.9 million; the filing does not clearly explain the difference in those presentations.
- Assess how sustainable the exceptionally rapid semiconductor-driven growth and margin improvement are, particularly given management’s flat Q4 comparison outlook and the industry’s cyclicality.
- Monitor customer concentration, order visibility and customer pricing power, as the two largest customers supplied 84.0% of nine-month sales.
- Track inventory, receivables, supplier commitments and cash conversion; the $169.2 million purchase commitment and working-capital build are significant relative to operating cash flow.
- Review debt availability, covenant headroom, foreign cash accessibility and tax consequences of any repatriation, as well as progress and costs of the ERP rollout.